微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -4.18% | -14.21% | -89.14% | 123/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | -2.21% | -140.22% | 86.4% | 123/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -16.25% | -322.08% | -203.17% | 124/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | -5.36% | -396.13% | -46.45% | 126/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -3.66% | -336.13% | -297.83% | 124/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | -0.92% | -197.87% | 76.1% | 118/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -3.85% | 6.1% | -312.71% | 113/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 1.81% | -30.92% | 16.77% | 91/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 1.55% | -27.57% | 64.89% | 83/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.94% | -52.04% | 122.93% | 78/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -4.1% | -390.78% | -256.49% | 116/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 2.62% | -59.32% | 22.43% | 92/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.14% | -47.93% | 9.18% | 83/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.96% | -64.68% | 39.01% | 57/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 1.41% | -85.89% | -78.11% | 109/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 6.44% | -51.58% | 56.69% | 76/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 4.11% | -38.93% | -25.95% | 77/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 5.55% | 22.79% | -44.44% | 27/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 9.99% | 285.71% | -24.89% | 84/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 13.3% | 235.01% | 97.62% | 45/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 6.73% | 345.7% | 48.89% | 59/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 4.52% | 638.1% | 74.52% | 35/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 2.59% | 688.64% | -34.76% | 115/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 3.97% | -20.44% | 162.91% | 74/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 1.51% | -36.29% | 279.76% | 97/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | -0.84% | -160.87% | -90.91% | 71/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | -0.44% | 96.46% | -108.82% | 110/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 4.99% | 9.19% | 110.55% | 47/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 2.37% | -29.46% | 71.74% | 59/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 1.38% | -1.43% | 111.09% | 38/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | -12.44% | -285.95% | -372.21% | 109/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 4.57% | -12.45% | 36.01% | 41/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 3.36% | 26.79% | 140% | 39/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 1.4% | 21.74% | -79.07% | 36/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 6.69% | 26.94% | 28.16% | 76/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 5.22% | 49.14% | 96.98% | 36/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 2.65% | 48.88% | 130.43% | 46/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 1.15% | 22.34% | -78.18% | 39/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 5.27% | -28.3% | 50.57% | 68/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 3.5% | -42.15% | 96.63% | 34/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 1.78% | -53.16% | 89.36% | 45/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 0.94% | -54.81% | -87.21% | 28/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |